Henan Genuine Biotech Co., Ltd.

This study tests a new drug called dositinib in people with advanced non-small cell lung cancer that has a specific genetic change (EGFR mutation). The goal is to find a safe dose and see if it shrinks tumors. About 153 adults aged 18-75 who have already tried other treatments wi…

This study tests a new experimental drug, CL-197, in 24 adults with HIV-1 who have never taken any HIV medication before. The goal is to see how well the drug lowers the amount of virus in the blood and to check for side effects over about two weeks. Participants will receive a s…

This study tests a new drug (GEN-725) combined with dositinib in 110 adults with advanced EGFR-mutant non-small cell lung cancer that cannot be surgically removed. The goal is to see if the combination is safe and shrinks tumors. This is not a cure; it aims to control the disease…

This early-phase study tests a new tablet called GEN-725 in 48 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants must be between …